More than 120K US kids had primary caregivers die during pandemic

The number of U.S. children orphaned during the COVID-19 pandemic may be larger than previously estimated, a new study suggests.

Cobb County School Board to discuss parent's COVID-19 lawsuit during closed-door meeting

A group of parents has sued the Cobb County School District over its COVID-19 policy. They claim the school board has not done enough to protect their medically vulnerable children.

Diaper shortage hits US amid COVID-19 pandemic, supply chain issues

The National Diaper Bank Network said the country has a diaper shortage with nearly 33% of American families in need of the baby item.

UW Medicine to deny organ transplants to unvaccinated patients

If you have not been vaccinated against COVID-19, you may have a hard time getting a transplant in western Washington.

US to increase at-home COVID-19 rapid test availability

The White House says the supply boost is the result of a new $1 billion federal investment, on top of the $2 billion committed to increasing the availability of the convenient diagnostic tests in September.

US seeks to prevent public housing evictions with new HUD rule

Public housing tenants cannot be evicted for nonpayment without 30 days' notice and information about federal emergency rental assistance under a new HUD rule.

Powder Springs offering employees $500 to get vaccinated

One small Georgia city is offering a big incentive to employees to get vaccinated. Powder Springs will give employees $500 dollars if they roll up their sleeves for the COVID vaccine.

Kaiser Permanente suspends 2,200 of its employees nationwide over vaccine mandate

Kaiser Permanente has placed more than 2,200 of its employees nationwide, who have refused to get vaccinated against COVID-19, on unpaid administrative leave.

Australia banning foreign tourists until at least 2022

Australia's prime minister says foreign tourists won’t be welcomed back until at least next year.

AstraZeneca asks FDA to authorize antibody treatment to prevent COVID-19

AstraZeneca said the treatment would be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention.